Journal of Surgical Oncology

Papers
(The H4-Index of Journal of Surgical Oncology is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Comparison of survival for metastatic pancreatic cancer patients treated with CPI‐613 versus resected borderline‐resectable pancreatic cancer patients65
Current monitoring and treatment for anal intraepithelial neoplasms58
48
JSO seminar series: Global inequities in access to cancer care and strategies to address them43
34
Extent of macroscopic vascular invasion predicts distant metastasis in primary leiomyosarcoma of the inferior vena cava30
Issue Information27
Local and National Trends in Emergency Presentation of Colon and Rectal Cancer26
Adoption of cytoreductive surgery in the management of peritoneal malignancies—Global trends26
Closure of pelvic peritoneum with bladder peritoneum flap reconstruction after laparoscopic extralevator abdominoperineal excision: A prospective stage II study24
Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma24
Delayed Esophagectomy After Chemoradiation Is Not Associated With Increased Mortality or Recurrence23
Variation in hospital utilization of palliative interventions for patients with advanced gastrointestinal cancer near end of life22
A novel mini‐retractor for retroperitoneal laparoscopic partial nephrectomy21
Prediction of symptomatic anastomotic leak after rectal cancer surgery21
Emerging innovations and advancements in the treatment of extremity and truncal soft tissue sarcomas21
Cancer risk‐reducing surgery: Brazilian Society of Surgical Oncology Guideline Part 2 (Gastrointestinal and thyroid)21
Treatment Modalities and Risks of Complication for Patients With Localized Renal Cell Carcinoma Aged 75 and Older20
20
Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy20
Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastases20
0.17861700057983